Page last updated: 2024-08-22

platinum and piperidines

platinum has been researched along with piperidines in 20 studies

Research

Studies (20)

TimeframeStudies, this research(%)All Research%
pre-19903 (15.00)18.7374
1990's0 (0.00)18.2507
2000's4 (20.00)29.6817
2010's7 (35.00)24.3611
2020's6 (30.00)2.80

Authors

AuthorsStudies
Grant, CW; McConnell, HM; Wu, SH1
Nigam, IC1
Guttenplan, JB; Miller, P; Safirstein, R1
Adjei, AA; Bruzek, LM; Davis, JN; Erlichman, C; Kaufmann, SH1
Kim, KH; Kim, KM; Song, R1
Brabec, V; Gibson, D; Kasparkova, J; Marini, V; Najajreh, Y; Novakova, O; Perez, JM1
Ardeli-Tzaraf, Y; Barenholz, Y; Brabec, V; Gibson, D; Kasparkova, J; Khazanov, E; Najajreh, Y; Perez, JM; Prilutski, D1
Cao, G; Huang, Y; Li, W; Liu, Q; Yao, S1
Amiri-Kordestani, L; Banerjee, A; Beaver, JA; Blumenthal, GM; Charlab, R; Chen, XH; Dave, K; Dinin, J; Eradiri, O; Ghosh, S; Goldberg, KB; Horne, HN; Howie, LJ; Ibrahim, A; Ison, G; Janoria, KG; Kelly, SL; Kluetz, PG; Lee, EY; Li, F; Manheng, W; Palmby, TR; Pazdur, R; Philip, R; Pierce, WF; Pierre, V; Ramamoorthy, A; Song, P; Sridhara, R; Tang, S; Yu, J; Zhang, L1
Konstantinopoulos, PA; Matulonis, UA1
Cilibrizzi, A; Ferraro, G; Infrasca, T; Marzo, T; Merlino, A; Messori, L; Vilar, R1
Wu, L; Zhong, L1
Schorge, JO1
Long, X; Zhou, Q; Zou, D1
Alvarez, N; Colombo, N; dePont Christensen, R; Gonzalez Martin, A; Heitz, F; Marqués, C; Meirovitz, M; Sanchez Lorenzo, L; Sanchez, J; Selle, F; van Gorp, T1
Liu, M; Liu, T; Sun, L; Tan, S; Tang, J; Xiao, W; Zhou, X1
Choi, MC; Jeong, DH; Kim, BG; Kim, SI; Lee, JK; Lee, JY; Lim, MC; Park, J1
Cancanelli, L; Chiumente, M; Di Spazio, L; Mengato, D; Messori, A; Rivano, M1
Belotte, J; Clements, A; Fleming, EL; Gray, HJ; Gupta, D; Hamilton, E; Hardesty, MM; Keeton, EK; Konecny, GE; Krivak, TC; Moore, RG; Richardson, DL; Wang, P; Wright, GS1
Domchek, SM; Donze, A; Gosselin, MK; Karasic, T; Massa, R; Mick, R; O'Hara, M; Onyiah, C; Reiss, KA; Schneider, C; Teitelbaum, U; Tondon, R; Vonderheide, RH1

Trials

4 trial(s) available for platinum and piperidines

ArticleYear
A phase III, randomized, double blinded trial of platinum based chemotherapy with or without atezolizumab followed by niraparib maintenance with or without atezolizumab in patients with recurrent ovarian, tubal, or peritoneal cancer and platinum treatment
    International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2021, Volume: 31, Issue:4

    Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Ovarian Epithelial; Double-Blind Method; Fallopian Tube Neoplasms; Female; Humans; Indazoles; Peritoneal Neoplasms; Piperidines; Platinum; Progression-Free Survival; Time Factors

2021
A single-arm, phase II study of niraparib and bevacizumab maintenance therapy in platinum-sensitive, recurrent ovarian cancer patients previously treated with a PARP inhibitor: Korean Gynecologic Oncology Group (KGOG 3056)/NIRVANA-R trial.
    Journal of gynecologic oncology, 2022, Volume: 33, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carcinoma, Ovarian Epithelial; Female; Humans; Indazoles; Neoplasm Recurrence, Local; Ovarian Neoplasms; Piperidines; Platinum; Poly(ADP-ribose) Polymerase Inhibitors; Republic of Korea

2022
OVARIO phase II trial of combination niraparib plus bevacizumab maintenance therapy in advanced ovarian cancer following first-line platinum-based chemotherapy with bevacizumab.
    Gynecologic oncology, 2022, Volume: 166, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Female; Humans; Indazoles; Maintenance Chemotherapy; Ovarian Neoplasms; Piperidines; Platinum

2022
Niraparib plus nivolumab or niraparib plus ipilimumab in patients with platinum-sensitive advanced pancreatic cancer: a randomised, phase 1b/2 trial.
    The Lancet. Oncology, 2022, Volume: 23, Issue:8

    Topics: Antineoplastic Combined Chemotherapy Protocols; Humans; Hypertension; Immune Checkpoint Inhibitors; Indazoles; Ipilimumab; Nivolumab; Pancreatic Neoplasms; Piperidines; Platinum; Poly(ADP-ribose) Polymerase Inhibitors

2022

Other Studies

16 other study(ies) available for platinum and piperidines

ArticleYear
Lateral phase separations in binary lipid mixtures: correlation between spin label and freeze-fracture electron microscopic studies.
    Biochimica et biophysica acta, 1974, Sep-06, Volume: 363, Issue:2

    Topics: Binding Sites; Chromatography; Chromatography, Thin Layer; Fatty Acids, Unsaturated; Kinetics; Liposomes; Membranes, Artificial; Microscopy, Electron; Models, Biological; Palmitic Acids; Phosphatidylcholines; Piperidines; Platinum; Potentiometry; Silicon Dioxide; Spin Labels; Temperature

1974
Reaction gas chromatography. I. Catalytic aromatization of alicyclic and heterocyclic compounds.
    Journal of chromatography, 1966, Volume: 24, Issue:1

    Topics: Alcohols; Amines; Catalysis; Chemical Phenomena; Chemistry; Chromatography, Gas; Cycloparaffins; Heterocyclic Compounds; Hydrocarbons; Ketones; Naphthalenes; Piperazines; Piperidines; Platinum; Pyrrolidines

1966
Uptake and metabolism of cisplatin by rat kidney.
    Kidney international, 1984, Volume: 25, Issue:5

    Topics: Animals; Binding Sites; Biological Transport; Biotransformation; Carbon Radioisotopes; Chromatography, High Pressure Liquid; Cisplatin; Kidney; Kidney Cortex; Male; Mutagenicity Tests; Organoplatinum Compounds; Piperidines; Platinum; Probenecid; Rats; Rats, Inbred Strains; Thiamine; Tolazoline

1984
Synergy of the protein farnesyltransferase inhibitor SCH66336 and cisplatin in human cancer cell lines.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2001, Volume: 7, Issue:5

    Topics: Alkyl and Aryl Transferases; Antineoplastic Agents; Apoptosis; Cell Cycle; Cisplatin; DNA Adducts; Drug Combinations; Drug Synergism; Fluorouracil; Humans; Melphalan; Piperidines; Platinum; Pyridines; Tumor Cells, Cultured

2001
A metal-centered hydrophobic pocket recognizing pyridine over piperidine.
    Journal of the American Chemical Society, 2003, Jun-18, Volume: 125, Issue:24

    Topics: Copper; Cyclohexylamines; Hydrophobic and Hydrophilic Interactions; Magnetic Resonance Spectroscopy; Models, Molecular; Molecular Conformation; Organometallic Compounds; Picolines; Piperidines; Platinum; Pyridines

2003
Activation of trans geometry in bifunctional mononuclear platinum complexes by a piperidine ligand. Mechanistic studies on antitumor action.
    The Journal of biological chemistry, 2003, Nov-28, Volume: 278, Issue:48

    Topics: Animals; Antineoplastic Agents; Base Sequence; CHO Cells; Cisplatin; Cricetinae; Cross-Linking Reagents; DNA; DNA Adducts; DNA Polymerase I; Dose-Response Relationship, Drug; HeLa Cells; HIV Reverse Transcriptase; Humans; Hydroxyl Radical; Ligands; Models, Chemical; Models, Theoretical; Molecular Sequence Data; Oligonucleotides; Piperidines; Platinum; Time Factors

2003
Structure and unique interactions with DNA of a cationic trans-platinum complex with the nonplanar bicyclic piperidinopiperidine ligand.
    Angewandte Chemie (International ed. in English), 2005, May-06, Volume: 44, Issue:19

    Topics: Antineoplastic Agents; Cell Line, Tumor; Cisplatin; Crystallography, X-Ray; DNA; DNA Adducts; Humans; Inhibitory Concentration 50; Ligands; Molecular Structure; Organoplatinum Compounds; Piperidines; Platinum

2005
Generation of gold nanostructures at the surface of platinum electrode by electrodeposition for ECL detection for CE.
    Electrophoresis, 2010, Volume: 31, Issue:6

    Topics: Electrochemical Techniques; Electrodes; Electrophoresis, Capillary; Electroplating; Gold; Humans; Hydrogen-Ion Concentration; Luminescent Measurements; Metal Nanoparticles; Piperidines; Platinum

2010
FDA Approval Summary: Niraparib for the Maintenance Treatment of Patients with Recurrent Ovarian Cancer in Response to Platinum-Based Chemotherapy.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2018, 09-01, Volume: 24, Issue:17

    Topics: Aged; BRCA1 Protein; BRCA2 Protein; Clinical Trials as Topic; Drug Approval; Drug-Related Side Effects and Adverse Reactions; Female; Germ-Line Mutation; Humans; Indazoles; Maintenance Chemotherapy; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Peritoneal Neoplasms; Piperidines; Platinum; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Progression-Free Survival; Risk Assessment

2018
PARP Inhibitors in Ovarian Cancer: A Trailblazing and Transformative Journey.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2018, 09-01, Volume: 24, Issue:17

    Topics: Female; Humans; Indazoles; Neoplasm Recurrence, Local; Ovarian Neoplasms; Piperidines; Platinum; Poly(ADP-ribose) Polymerase Inhibitors

2018
A case of extensive protein platination: the reaction of lysozyme with a Pt(ii)-terpyridine complex.
    Dalton transactions (Cambridge, England : 2003), 2018, Jul-03, Volume: 47, Issue:26

    Topics: Crystallography, X-Ray; Dimethyl Sulfoxide; Hydrogen-Ion Concentration; Ligands; Lysine; Molecular Conformation; Muramidase; Organoplatinum Compounds; Piperidines; Platinum; Protein Binding; Pyridines; Spectrometry, Mass, Electrospray Ionization; Succinic Acid; Water

2018
Budget impact analysis of niraparib and olaparib for maintenance treatment of platinum-sensitive, recurrent ovarian cancer in the US.
    Journal of medical economics, 2019, Volume: 22, Issue:2

    Topics: Antineoplastic Agents; Budgets; Female; Health Expenditures; Humans; Indazoles; Models, Econometric; Neoplasm Recurrence, Local; Ovarian Neoplasms; Phthalazines; Piperazines; Piperidines; Platinum; Poly(ADP-ribose) Polymerase Inhibitors; Progression-Free Survival; Survival Analysis; United States

2019
Chemotherapy-free, but not quite free chemotherapy.
    The Lancet. Oncology, 2019, Volume: 20, Issue:10

    Topics: Bevacizumab; Female; Humans; Indazoles; Neoplasm Recurrence, Local; Ovarian Neoplasms; Piperidines; Platinum

2019
Chemotherapy-free strategy for platinum-sensitive recurrent ovarian cancer.
    The Lancet. Oncology, 2019, Volume: 20, Issue:12

    Topics: Bevacizumab; Female; Humans; Indazoles; Neoplasm Recurrence, Local; Ovarian Neoplasms; Piperidines; Platinum

2019
Chronic stress induces platinum and Niraparib resistance in mouse models of ovarian cancer.
    Experimental cell research, 2022, 01-15, Volume: 410, Issue:2

    Topics: Animals; Cell Line, Tumor; Disease Models, Animal; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Gene Regulatory Networks; Humans; Indazoles; Mice, Inbred BALB C; Mice, Inbred C57BL; Middle Aged; Models, Biological; Ovarian Neoplasms; Piperidines; Platinum; Stress, Psychological

2022
Indirect comparison of three PARP inhibitors (olaparib, niraparib, and rucaparib) as maintenance treatment in ovarian carcinoma patients responding to platinum therapy.
    International journal of clinical pharmacology and therapeutics, 2022, Volume: 60, Issue:8

    Topics: Carcinoma, Ovarian Epithelial; Female; Humans; Indazoles; Indoles; Ovarian Neoplasms; Phthalazines; Piperazines; Piperidines; Platinum; Poly(ADP-ribose) Polymerase Inhibitors

2022